[1]何佳玲 叶滔 周名纲 蔡琳.静脉-动脉体外膜肺氧合在心脏危重症中的救治[J].心血管病学进展,2021,(3):256-261.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.016]
 HE Jialing,YE Tao,ZHOU Minggang,et al.Application of Veno-arterial Extracorporeal Membrane Oxygenation in Critical Cardiac Disease[J].Advances in Cardiovascular Diseases,2021,(3):256-261.[doi:10.16806/j.cnki.issn.1004-3934.2021.03.016]
点击复制

静脉-动脉体外膜肺氧合在心脏危重症中的救治()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年3期
页码:
256-261
栏目:
出版日期:
2021-03-25

文章信息/Info

Title:
Application of Veno-arterial Extracorporeal Membrane Oxygenation in Critical Cardiac Disease
作者:
何佳玲 叶滔 周名纲 蔡琳
(西南交通大学附属医院 成都市第三人民医院心内科,四川 成都 610031)
Author(s):
HE Jialing YE Tao ZHOU MinggangCAI Lin
(Department of Cardiology,The Third People’s Hospital of Chengdu,The Affiliated Hospital of Southwest Jiaotong University,Chengdu 610031,Sichuan,China)
关键词:
静脉-动脉体外膜肺氧合心脏危重症心源性休克心搏骤停
Keywords:
Veno-arterial extracorporeal membrane oxygenationCritical cardiac diseaseCardiac shockSudden cardiac arrest
DOI:
10.16806/j.cnki.issn.1004-3934.2021.03.016
摘要:
中国的心血管疾病负担较重,冠心病和心力衰竭等心脏疾病可导致心源性休克和心搏骤停。静脉-动脉体外膜肺氧合是救治心脏危急重症的重要手段。现通过1例体外膜肺氧合救治成功的心肌梗死合并心源性休克病例,引出体外膜肺氧合在心脏危急重症中救治的探讨,包括体外膜肺氧合机制、适应证与禁忌证、国内外研究进展、应用现状和展望等方面。
Abstract:
China’s cardiovascular disease burden is heavy. Coronary heart disease, heart failure and other heart diseases can lead to cardiac shock and sudden cardiac arrest. Veno-arterial e xtracorporeal membrane oxygenation is an important method of treating critical heart disease. This paper began from a successfully saved case of myocardial infarction induced cardiac shock with the help of veno-arterial extracorporeal membrane oxygenation. And then we develop a review of application of extracorporeal membrane oxygenation in critical cardiac disease,including the following aspects:mechanism of extracorporeal membrane oxygenation,indications and contraindications,research progress at home and abroad,and application status and prospection

参考文献/References:

[1] Thiele H,Zeymer U,Neumann FJ,et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. N Engl J Med,2012,367(14):1287-1296.

[2] Nagao K,Nonogi H,Yonemoto N,et al. Duration of prehospital resuscitation efforts after out-of-hospital cardiac arrest[J]. Circulation,2016,133(14):1386-1396.

[3] 杨峰,王粮山. 成人体外膜氧合循环辅助专家共识[J]. 中华重症医学电子杂志(网络版) ,2018,4(2):114-122.

[4] Kolff WJ,Berk HT,ter Welle M,et al. The artificial kidney:a dialyser with a great area.1944[J]. J Am Soc Nephrol,1997,8(12):1959-1965.

[5] Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery[J]. Minn Med,1954,37(3):171-185;passim.

[6] Napp LC,Kuhn C,Bauersachs J. ECMO in cardiac arrest and cardiogenic shock[J]. Herz,2017,42(1):27-44.

[7] Burkhoff D,Naidu SS. The science behind percutaneous hemodynamic support:a review and comparison of support strategies[J]. Catheter Cardiovasc Interv,2012,80(5):816-829.

[8] Soleimani B,Pae WE. Management of left ventricular distension during peripheral extracorporeal membrane oxygenation for cardiogenic shock[J]. Perfusion,2012,27(4):326-331.

[9] Fraser JF,Shekar K,Diab S,et al. ECMO—the clinician’s view[J]. ISBT Sci Series,2012,7(1):82-88.

[10] Cheng R,Hachamovitch R,Kittleson M,et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest:a meta-analysis of 1,866 adult patients[J]. Ann Thorac Surg ,2014,97(2):610-616.

[11] Reyentovich A,Barghash MH,Hochman JS. Management of refractory cardiogenic shock[J]. Nat Rev Cardiol,2016,13(8):481-492.

[12] Hochman JS,Buller CE,Sleeper LA,et al. Cardiogenic shock complicating acute myocardial infarction—etiologies,management and outcome:a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?[J]. J Am Coll Cardiol ,2000,36(3 suppl A):1063-1070.

[13] Windecker S,Kolh P,Alfonso F,et al. 2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC) and the European Association for Cardio-Thoracic Surgery(EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J]. Eur Heart J,2014,35(37):2541-2619.

[14] Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology(ESC) and European Association for Cardio-Thoracic Surgery(EACTS)[J]. G Ital Cardiol(Rome) ,2019,20(7-8 suppl 1):1s-61s.

[15] Yancy CW,Jessup M,Bozkurt B,et al. 2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines[J]. Circulation,2013,128(16):e240-e327.

[16] Aso S,Matsui H,Fushimi K,et al. In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation:analysis of 5,263 patients using a national inpatient database in Japan[J]. Crit Care,2016,20:80.

[17] Muller G,Flecher E,Lebreton G,et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock[J]. Intensive Care Med,2016,42(3):370-378.

[18] Sheu JJ,Tsai TH,Lee FY,et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock[J]. Crit Care Med,2010,38(9):1810-1817.

[19] Sattler S,Khaladj N,Zaruba MM,et al. Extracorporal life support(ECLS) in acute ischaemic cardiogenic shock[J]. Int J Clin Pract,2014,68(4):529-531.

[20] Riebandt J,Haberl T,Mahr S,et al. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device(aEuro)[J]. Eur J C ardiothorac Surg,2014,46(3):486-492.

[21] 田峰,周珊珊,张弢,等. 主动脉内球囊反搏联合体外膜肺氧合在急性心肌梗死合并心原性休克患者救治中的应用[J]. 中国介入心脏病学杂志 ,2019,27(11):614-618.

[22] 侯剑峰,陈凯,唐汉韡,等. 体外膜肺氧合与主动脉球囊反搏联合辅助救治心血管外科术后心原性休克:阜外医院单中心十一年经验总结[J]. 中 国循环杂志,2019,34(1):66-71.

[23] Schmidt M,Burrell A,Roberts L,et al. Predicting survival after ECMO for refractory cardiogenic shock:the survival after veno-arterial-ECMO (SAVE)-score[J]. Eur Heart J,2015,36(33):2246-2256.

[24] Muller G,Flecher E,Lebreton G,et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock[J]. Intensive Care Med,2016,42(3):370-378.

[25] Brooks SC,Anderson ML,Bruder E,et al. Part 6:Alternative Techniques and Ancillary Devices for Cardiopulmonary Resuscitation:2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care[J]. Circulation,2015,132(18 suppl 2):S436-S443.

[26] Chen YS,Lin JW,Yu HY,et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest:an observational study and propensity analysis[J]. Lancet,2008,372(9638):554-561.

[27] Mosier JM,Kelsey M,Raz Y,et al. Extracorporeal membrane oxygenation(ECMO) for critically ill adults in the emergency department:history,current applications,and future directions[J]. Crit Care,2015,19:431.

[28] Chung SY,Sheu JJ,Lin YJ,et al. Outcome of patients with profound cardiogenic shock after cardiopulmonary resuscitation and prompt extracorporeal membrane oxygenation support. A single-center observational study[J]. Circ J, 2012,76(6):1385-1392.

[29] le Guen M,Nicolas-Robin A,Carreira S,et al. Extracorporeal life support following out-of-hospital refractory cardiac arrest[J]. Crit Care,2011,15(1):R29.

[30] Stub D,Bernard S,Pellegrino V,et al. Refractory cardiac arrest treated with mechanical CPR,hypothermia,ECMO and early reperfusion(the CHEER trial)[J]. Resuscitation,2015,86:88-94.

[31] Avalli L,Maggioni E,Formica F,et al. Favourable survival of in-hospital compared to out-of-hospital refractory cardiac arrest patients treated with extracorporeal membrane oxygenation:an Italian tertiary care centre experience[J]. Resuscitation,2012,83(5):579-583.

[32] Leick J,Liebetrau C,Szardien S,et al. Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest[J]. Clin R es C ardiol,2013,102(9):661-669.

[33] Pozzi M,Koffel C,Armoiry X,et al. Extracorporeal life support for refractory out-of-hospital cardiac arrest:should we still fight for? A single-centre,5-year experience[J]. Int J Cardiol,2016,204:70-76.

[34] Richardson AS,Schmidt M,Bailey M,et al. ECMO Cardio-Pulmonary Resuscitation (ECPR),trends in survival from an international multicentre cohort study over 12-years[J]. Resuscitation,2017,112:34-40.

[35] 中国生物医学工程学会体外循环分会. 2017与2018年中国心外科手术和体外循环数据白皮书[J]. 中国体外循环杂志,2019,17(5):257-260.

[36] 胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志 ,2019,34(3):209-220.

更新日期/Last Update: 2021-05-27